Literature DB >> 17173492

Value-based insurance design: aligning incentives to bridge the divide between quality improvement and cost containment.

A Mark Fendrick1, Michael E Chernew.   

Abstract

Rising costs and suboptimal clinical quality have spawned efforts to redesign healthcare benefit packages. Momentum has gathered behind 2 trends; the first, represented by disease management initiatives and pay-for-performance programs, focuses on the quality of care, and uses tools to manage patient health. The second trend, represented by increased patient cost sharing and consumer-driven health plans, focuses on the cost of care and uses financial incentives to alter patient and provider behavior. These 2 trends create a conflict for the patient in that disease management programs--designed to improve patient self-management--aim to enhance compliance with specific clinical interventions, while rising copayments create financial barriers that discourage the use of these recommended services. When patients are required to pay more for their healthcare, they buy less, even if the intervention is potentially lifesaving. Thus, the challenge for purchasers is to devise benefit packages that incorporate a range of features that complement each other in the effective and efficient delivery of care while explicitly avoiding the unwanted negative clinical effects associated with increased cost sharing.

Entities:  

Mesh:

Year:  2006        PMID: 17173492

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  11 in total

1.  Using financial incentives to improve value in orthopaedics.

Authors:  David Lansky; Benedict U Nwachukwu; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2012-04       Impact factor: 4.176

2.  Is the US "leading from behind" on health policy?

Authors:  Peter J Neumann; Cayla J Saret
Journal:  Eur J Health Econ       Date:  2013-12-10

3.  Value and increased cost sharing in the American health care system.

Authors:  Michael Chernew; A Mark Fendrick
Journal:  Health Serv Res       Date:  2008-04       Impact factor: 3.402

4.  Prescription copay reduction program for diabetic employees: impact on medication compliance and healthcare costs and utilization.

Authors:  Kavita V Nair; Kerri Miller; Joseph Saseen; Pamela Wolfe; Richard Read Allen; Jinhee Park
Journal:  Am Health Drug Benefits       Date:  2009-01

5.  Relationship of asthma management, socioeconomic status, and medication insurance characteristics to exacerbation frequency in children with asthma.

Authors:  Wendy J Ungar; J Michael Paterson; Tara Gomes; Peter Bikangaga; Milton Gold; Teresa To; Anita L Kozyrskyj
Journal:  Ann Allergy Asthma Immunol       Date:  2010-11-20       Impact factor: 6.347

6.  Impact of consumer-directed health plans on low-value healthcare.

Authors:  Rachel O Reid; Brendan Rabideau; Neeraj Sood
Journal:  Am J Manag Care       Date:  2017-12       Impact factor: 2.229

7.  Trends in patient cost sharing for clinical services used as quality indicators.

Authors:  Michael Chernew; Teresa B Gibson; A Mark Fendrick
Journal:  J Gen Intern Med       Date:  2010-03       Impact factor: 5.128

8.  Emerging lessons from regional and state innovation in value-based payment reform: balancing collaboration and disruptive innovation.

Authors:  Douglas A Conrad; David Grembowski; Susan E Hernandez; Bernard Lau; Miriam Marcus-Smith
Journal:  Milbank Q       Date:  2014-09       Impact factor: 4.911

9.  Explaining regional variations in health care utilization between Swiss cantons using panel econometric models.

Authors:  Paul A Camenzind
Journal:  BMC Health Serv Res       Date:  2012-03-13       Impact factor: 2.655

10.  Impact of emerging health insurance arrangements on diabetes outcomes and disparities: rationale and study design.

Authors:  J Frank Wharam; Steve Soumerai; Connie Trinacty; Emma Eggleston; Fang Zhang; Robert LeCates; Claire Canning; Dennis Ross-Degnan
Journal:  Prev Chronic Dis       Date:  2013       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.